中耳胆脂瘤患者手术前后生活质量的评价分析

许丽丽;张文;王鑫;刘晖;王冰;张瑾;张韩

1:西安医学院

2:陕西省人民医院耳鼻咽喉头颈外科

摘要
目的 探讨中耳胆脂瘤及手术干预对患者生活质量的影响。方法 使用苏黎世慢性中耳炎量表(the Zurich chronic middle ear inventory, ZCMEI-21))评估53例(53耳)行手术治疗的中耳胆脂瘤患者的生活质量,该量表包括耳部体征和症状、听力水平、心理社会影响和医疗资源的使用情况四个方面;患者术前和术后6~12个月均完成纯音听力检查和ZCMEI-21量表的填写,分析一般情况、听力水平、手术干预对患者生活质量的影响。结果 不同年龄、性别、职业、居住环境患者ZCMEI-21量表评分差异无统计学意义(P>0.05);手术干预前耳部体征和症状、听力水平、社会心理影响和医疗资源使用情况分量表评分及ZCMEI-21量表总分明显高于手术后,差异有统计学意义(均为P<0.05)。患者手术前后ZCMEI-21量表总评分与平均气导听阈差值之间中度相关(r=0.518,P<0.001,与手术前后气骨导差值变化之间无相关性(r=0.062,P=0.658)。结论 手术干预可显著改善中耳胆脂瘤患者的生活质量,术后患者听力恢复情况与生活质量的影响显著相关。
关键词
中耳胆脂瘤;生活质量;苏黎世慢性中耳炎量表
基金项目(Foundation):
陕西省重点研发计划(2018ZDXM-SF-048)
作者
许丽丽;张文;王鑫;刘晖;王冰;张瑾;张韩
参考文献

1 Luntz M,Barzilai R.Middle ear cholesteatoma[J].Harefuah,2021,160(5):316-322.

2 Prabhu P,Chandrashekar A,Jose A,et al.Development and administration of chronic suppurative otitis media questionnaire-12 (COMQ-12) and chronic otitis media outcome test-15 (COMOT-15) in Kannada[J].Int Arch Otorhinolaryngol,2018,22(2):108-112.

3 Lailach S,Kemper M,Lasurashvili N,et al.Health-related quality of life measurement after cholesteatoma surgery:comparison of three different surgical techniques[J].Eur Arch Otorhinolaryngol,2015,272(11):3177-3185.

4 Chatzimichalis M,Epprecht L,Weder S,et al.English translation and validation of the Zurich chronic middle ear inventory (ZCMEI-21-E) assessing quality of life in chronic otitis media:a prospective international multicentre study[J].Clin Otolaryngol,2019,44(3):254-262.

5 B?chinger D,Takagi D,Yamada H,et al.Japanese translation,cross-cultural adaption and multicentre validation of the Zurich chronic middle ear inventory (ZCMEI-21-Jap)[J].Auris Nasus Larynx,2019,46(1):18-23.

6 Ralli M,Quaranta N,Canale A,et al.Cross-cultural adaption and validation of the zurich chronic middle ear inventory translated into italian (ZCMEI-21-It)-a prospective multicenter study[J].Otol Neurotol,2019,40(3):351-358.

7 Tutar B,Saltürk Z,Berkiten G,et al.A novel Turkish instrument for assessing quality of life in chronic otitis media-translation and validation of Zurich chronic middle ear inventory[J].Turk J Med Sci,2020,50(8):1922-1929.

8 Yang R,Zhang Y,Han W,et al.Measuring health-related quality of life in chronic otitis media in a Chinese population:cultural adaption and validation of the Zurich chronic middle ear inventory (ZCMEI-21-Chn)[J].Health Qual Life Outcomes,2020,18(1):218.

9 Killeen DE,Tolisano AM,Kou YF,et al.Recidivism after endoscopic treatment of cholesteatoma[J].Otol Neurotol,2019,40(10):1313-1321.

10 Weiss NM,B?chinger D,Rrahmani A,et al.Mapping the ChOLE classification to hearing outcomes and disease-specific health-related quality of life[J].Eur Arch Otorhinolaryngol,2020,277(10):2729-2738.

11 Quaranta N,Iannuzzi L,Petrone P,et al.Quality of life after cholesteatoma surgery:intact-canal wall tympanoplasty versus canal wall-down tympanoplasty with mastoid obliteration[J].Ann Otol Rhinol Laryngol,2014,123(2):89-93.